Yupei Chen

9PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsRadiation therapyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

|Mar 05, 2026
Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity.

Zhenji Deng, Chuqing Zhang, Hanmiao Wei

|Aug 26, 2025
MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk Stratification.

Guan-Jie Qin, Wei Jiang, Wu-Qi Zhang

|Feb 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial.

Ling-Long Tang, Lin Chen, Gui-Qiong Xu

|Jun 06, 2023
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment.

Jiawei Lv, Yuan Wei, Jian-Hua Yin

|Jan 06, 2023
TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.

Ya-Qin Wang, Dong-Hong Wu, Denghui Wei

Pageof 2

Frequent Collaborators

9 joint publications

Jun Ma

5 joint publications

Ling-Long Tang

4 joint publications

Wen-Fei Li

4 joint publications

Na Liu